Spaccapelo Lab

Università degli Studi di Perugia

Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients


Journal article


Elisabetta Schiaroli, Anna Gidari, Giovanni Brachelente, Giulia Bicchieraro, Roberta Spaccapelo, Sabrina Bastianelli, Sara Pierucci, Chiara Busti, Carlo Pallotto, Lisa Malincarne, Barbara Camilloni, Flavio Falcinelli, Giuseppe Vittorio De Socio, Alfredo Villa, Antonella Mencacci, Daniela Francisci
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology, vol. 168, 2023 Nov, p. 105584


Cite

Cite

APA   Click to copy
Schiaroli, E., Gidari, A., Brachelente, G., Bicchieraro, G., Spaccapelo, R., Bastianelli, S., … Francisci, D. (2023). Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against {Omicron} {BA}.5. {A} real-world experience in booster vaccinated immunocompromised patients. Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology, 168, 105584. https://doi.org/10.1016/j.jcv.2023.105584


Chicago/Turabian   Click to copy
Schiaroli, Elisabetta, Anna Gidari, Giovanni Brachelente, Giulia Bicchieraro, Roberta Spaccapelo, Sabrina Bastianelli, Sara Pierucci, et al. “Impaired Neutralizing Antibody Efficacy of Tixagevimab-Cilgavimab 150+150 Mg as Pre-Exposure Prophylaxis against {Omicron} {BA}.5. {A} Real-World Experience in Booster Vaccinated Immunocompromised Patients.” Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 168 (November 2023): 105584.


MLA   Click to copy
Schiaroli, Elisabetta, et al. “Impaired Neutralizing Antibody Efficacy of Tixagevimab-Cilgavimab 150+150 Mg as Pre-Exposure Prophylaxis against {Omicron} {BA}.5. {A} Real-World Experience in Booster Vaccinated Immunocompromised Patients.” Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology, vol. 168, Nov. 2023, p. 105584, doi:10.1016/j.jcv.2023.105584.


BibTeX   Click to copy

@article{schiaroli2023a,
  title = {Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against {Omicron} {BA}.5. {A} real-world experience in booster vaccinated immunocompromised patients},
  year = {2023},
  month = nov,
  journal = {Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology},
  pages = {105584},
  volume = {168},
  doi = {10.1016/j.jcv.2023.105584},
  author = {Schiaroli, Elisabetta and Gidari, Anna and Brachelente, Giovanni and Bicchieraro, Giulia and Spaccapelo, Roberta and Bastianelli, Sabrina and Pierucci, Sara and Busti, Chiara and Pallotto, Carlo and Malincarne, Lisa and Camilloni, Barbara and Falcinelli, Flavio and De Socio, Giuseppe Vittorio and Villa, Alfredo and Mencacci, Antonella and Francisci, Daniela},
  month_numeric = {11}
}



Tools
Translate to